One-fourth of the 4 million California residents who rely on insulin for their diabetes can’t afford it, according to the LA Times.
A spokesperson for Gov. Gavin Newsom told the LA Times the administration is probing state lawmakers to invest $100 million into CalRx to produce insulin “in the next few years.”
The plan has a long way to go, though, as the industry’s complicated relationship with pharmacy benefits managers could halt action before any traction is made.
Mr. Newsom’s proposal will be debated by state lawmakers this summer.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
